Blended learning for entrepreneurial biomedical professionals

Paul Janssen Futurelab Leiden is an international blended learning (online and on-campus) program for entrepreneurial biomedical professionals.

profile of On-campus

Ready to go on campus? Join us June 4 at Castle Oud-Poelgeest

Read more

profile of Theme 2 Legislation live

Free course theme “Mandatory Review of Medical Research” is now live

Start course

On campus

Experience the on-campus

For four days, you will further explore question-based development in the beautiful setting of the castle and hotel Oud-Poelgeest. With a small group of maximum 30 course participants, you will reside at the castle and examine teaching cases that are based on real events. In “what really happened” sessions, invited speakers discuss the actual choices that were made during the case.


Read more

A selection of our contributors

Erik Niks MD PhD

Erik Niks MD PhD

Neurologist - Pediatric neurologist
Leiden University Medical Center

Piet Hinoul

Piet Hinoul

Global Head, Pre-Clinical, Clinical and Medical Affairs
J&J Ethicon

Prof. Ad Sitsen MD PhD

Prof. Ad Sitsen MD PhD

Owner
ClinPharMed Consultancy for Drug Development

Wim Parys

Wim Parys

Head of R&D Global Public Health
Janssen Pharmaceutica

Eline Bunnik

Eline Bunnik

Assistant professor Medical Ethics and Philosophy of Medicine
Erasmus MC

Maurits Westerik

Maurits Westerik

Senior Counsel
Bird & Bird

Andrea Kamage

Andrea Kamage

Patent Group Leader
Johnson & Johnson

Bart Swinkels

Bart Swinkels

Partner
NLO

Karin Verzijden

Karin Verzijden

Food and Pharma Lawyer
Axon Lawyers

Ineke Jonker-Hoogerkamp

Ineke Jonker-Hoogerkamp

Consultant Regulatory Affairs and Drug Development
Eagle Pharma Consult

Kees Recourt

Kees Recourt

Investment Manager
Mibiton Foundation

Paul Stoffels

Paul Stoffels

Chief scientific officer
Johnson & Johnson

Tom Huizinga

Tom Huizinga

Head of the Department of Rheumatology
Leiden University Medical Centre

Marcel Kenter

Marcel Kenter

Director
Paul Janssen Futurelab Leiden

Koen Andries

Koen Andries

VP Scientific Fellow Infectious Diseases Discovery
Janssen Pharmaceutica NV

Andreas Wallnöfer

Andreas Wallnöfer

General Partner
BioMed Partners Venture Capital (former Head of Clinical Research & Exploratory Development at F. Hoffmann-La Roche Ltd.)

Justin Hay

Justin Hay

Pharmacokinetics Assessor
Medicines and Healthcare products Regulatory Agency

André Elferink

André Elferink

Clinical epidemiologist
Dutch Medicines Evaluation Board

Rob Zuiker

Rob Zuiker

Senior Clinical Scientist
CHDR

Barbara J. van Zwieten-Boot

Barbara J. van Zwieten-Boot

Vice Chair
Medicines Evaluation Board, The Netherlands

Hans-Georg Eichler

Hans-Georg Eichler

Senior Medical Officer
European Medicines Agency

Robert Klautz

Robert Klautz

Thoracic Surgeon
Leiden University Medical Centre

Matthijs Moerland

Matthijs Moerland

Research Director Translational Biomarkers
CHDR

Joris Rotmans, MD, PhD

Joris Rotmans, MD, PhD

internist-nephrologist
LUMC

Janneke Meulenberg

Janneke Meulenberg

CEO
Arthrogen

Inge de Lepeleire

Inge de Lepeleire

Director Translational Pharmacology
MSD Europe

Koos Burggraaf

Koos Burggraaf

Research Director CVS & Metabolism
CHDR

Johan Garssen

Johan Garssen

Director Immunology Platform
Danone/Nutricia Research

Ingrid de Visser

Ingrid de Visser

Senior Clinical Scientist
CHDR

Rick Kuntz

Rick Kuntz

Senior Vice President and Chief Scientific, Clinical and Regulatory Officer
Medtronic

Geert Jan Groeneveld

Geert Jan Groeneveld

Research Director CNS
CHDR

Oliver Bisazza

Oliver Bisazza

Director Regulatory Policy
Medtronic

Saco de Visser

Saco de Visser

Head of Education and Clinical Pharmacologist
Paul Janssen Futurelab Leiden

Adam Cohen

Adam Cohen

CEO and clinical pharmacologist
Centre for Human Drug Research

Richard Shull

Richard Shull

Head of Deal Structuring and Trading Fundamentals
Shell

Pierre Peeters

Pierre Peeters

Former site head early stage development
Organon

Our approach in professional learning

We offer a unique blend of online education and on-campus training for talented biomedical scientist that have the ambition to become the future generation Chief Scientific Officers.

Stay connected

Quote Paul Janssen Futurelab

The mix worked well

"I was impressed with the versatility of the learning environment. The mix of texts, PDFs, videos, questions and assignments worked wonderfully well!"

Erik van Beers, Skyline DX, Clinical Development Online graduate

Quote Paul Janssen Futurelab

Not the traditional classroom

"Clinical development was dissected in a different way than I am used to, which was intriguing. The interface of the online course and exam were really nice: simple and straightforward to interact with, at your own pace and time, and you can go back and forth as you wish, certainly not the traditional way of a frontal classroom interface!”

Ofer Spiegelstein, Teva Pharmaceutical Industries Ltd, Clinical Development Online graduate

Quote Paul Janssen Futurelab

Really instructive

"The highlights of the course were the real life examples and the follow up provided. The interviews with people that were involved in the studies were really instructive"

Georges Habineza Ndikuyeze, Janssen Research & Development, Clinical Development Online graduate

Quote Paul Janssen Futurelab

Excellent learning opportunities

“The cases were excellent and the manner in which they were presented provided excellent learning opportunities”

Vickas Patel, GlaxoSmithKline, Clinical Development Online graduate

Quote Paul Janssen Futurelab

A world of knowledge

"This training opened my eyes to a whole new world of knowledge on the development of medical interventions"

Willem Birkhoff, Centre for Human Drug Research, Clinical Development Online graduate

Quote Paul Janssen Futurelab

Happy with responses

“Real life case studies and learning about 'how it really happened'. Very happy with responses on comments (timewise and content)”

Joost van Middendorp, Pfizer, Clinical Development Online graduate

After on-campus comes extended! Today participants meet their mentor and start writing their #clinicaltrial protocols to win the PJFL nomination letter for €500,000 @ZonMw #grant

Twitter image

It was great to host this year's on-campus group. Thank you all for making this course a success! https://t.co/BX15OKQoZ9

Twitter image

Ready for two weeks of exciting cases and interesting speaker @ Clinical Development on-campus! #clinicaltrials #biomedicine https://t.co/7yQajGNoMA

Meta Roestenberg, physician scientist at LUMC and PJFL alumnus wins Boehringen-Ingelheim prize. Congratulations Meta! https://t.co/QMWd69TC7L